MAL anticorps

N° du produit ABIN7881698

Cet anticorps anti-MAL Polyclonal Lapin (ABIN7881698) détecte spécifiquement MAL dans WB. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour MAL anticorps (ABIN7881698)

Antigène: MAL (Myelin and Lymphocyte Protein, T Cell Differentiation Protein (MAL))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MAL est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-MAL anticorps

Fonction: MAL Antibody / Myelin and lymphocyte protein

Séquence: HAVFSLIRWK SS

Purification: Affinity purified

Immunogène: Amino acids HAVFSLIRWKSS from the human protein were used as the immunogen for the MAL antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the MAL antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

Stock: 4 °C,-20 °C

Stockage commentaire: After reconstitution, the MAL antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Détails sur MAL

Antigène: MAL (Myelin and Lymphocyte Protein, T Cell Differentiation Protein (MAL))

Autre désignation: MAL

Sujet: Myelin and lymphocyte protein is a protein that in humans is encoded by the MAL gene. The protein encoded by this gene is a highly hydrophobic integral membrane protein belonging to the MAL family of proteolipids. The protein has been localized to the endoplasmic reticulum of T-cells and is a candidate linker protein in T-cell signal transduction. In addition, this proteolipid is localized in compact myelin of cells in the nervous system and has been implicated in myelin biogenesis and/or function. The protein plays a role in the formation, stabilization and maintenance of glycosphingolipid-enriched membrane microdomains. Down-regulation of this gene has been associated with a variety of human epithelial malignancies. Alternative splicing produces four transcript variants which vary from each other by the presence or absence of alternatively spliced exons 2 and 3.

UniProt: P21145

Pathways: Asymmetric Protein Localization